Drug Information

Drug General Information
Drug ID
D0Z6BZ
Former ID
DNC013788
Drug Name
Biphenyl-3-ylcarbamic Acid Biphenyl-3-yl Ester
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529498]
Structure
Download
2D MOL

3D MOL
Formula
C25H19NO2
Canonical SMILES
C1=CC=C(C=C1)C2=CC(=CC=C2)NC(=O)OC3=CC=CC(=C3)C4=CC=CC=<br />C4
InChI
1S/C25H19NO2/c27-25(26-23-15-7-13-21(17-23)19-9-3-1-4-10-19)28-24-16-8-14-22(18-24)20-11-5-2-6-12-20/h1-18H,(H,26,27)
InChIKey
GJGNAZXEUGJLTC-UHFFFAOYSA-N
PubChem Compound ID
44585895
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529498]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529498J Med Chem. 2008 Jun 26;51(12):3487-98. Epub 2008 May 29.Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.
Ref 529498J Med Chem. 2008 Jun 26;51(12):3487-98. Epub 2008 May 29.Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.